Today, Skuldtech is searching new funds and new investors to:
A – Finance its R&D programs associated to personalized medicine,
B – Hire staff and invest to meet the increasing demand for its services in
genomics, pharmacogenomics and transcriptomics.
To obtain more information about Skuldtech, please contact
our financial department: +33(0)467 419 748.
Skuldtech is specialized in the discovery of
new Biomarkers and the development of Diagnostics
focused on personalized medicine applications.
This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics
associated with new treatments, especially in
cancer, neurodegenerative and infectious diseases.